未登录

尚

尚卓 (Zhuo Shang)

University of Texas at Austin

H指数:23

被引数:1,511

个人简介

现任山东大学药学院教授。2004年9月至2008年6月毕业于中国农业大学，获学士学位，专业为食品质量与安全；2008年9月至2011年7月毕业于中国科学院海洋研究所，获硕士学位，专业为海洋药物学；2012年4月至2016年6月毕业于昆士兰大学，获博士学位，专业为天然药物化学。2016年9月至2018年2月任加州大学圣地亚哥分校Scripps海洋研究所博士后；2018年3月至2019年4月任洛克菲勒大学博士后；2019年5月至2020年4月任南卡罗莱纳大学研究助理；2020年5月至2022年5月任西澳大学研究助理。

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Genome mining of the tumor microbiome reveals biosynthetic diversity and potential pathology-modulating metabolites

肿瘤微生物组的基因组挖掘揭示了生物合成多样性和潜在的病理学调节代谢物

Nature Communications

IF15.7

2026-10-010

OA

Cinnamoyl-containing non-ribosomal peptides: discovery; bioactivity and biosynthesis

含肉桂酰基的非核糖体肽：发现；生物活性与生物合成

nat. prod. rep.

IF0

2026-06-220

PRE

Relationships of Upper respiratory tract infections and holistic diets and lifestyles in Northeast China

IF2.2

2025-10-210

OAAI

A broad-spectrum antibiotic targets multiple-drug-resistant bacteria with dual binding targets and no detectable resistance

广谱抗生素以双重结合靶点靶向多药耐药细菌且无可检测耐药性

Nature Communications

IF15.7

2025-07-310

OAAI

Biosynthesis of antitumor warkmycins reveals spatiotemporal order of the tailoring steps involving multiple glycosylation, hydroxylation, dual O-acetylation and carbamoylation

抗肿瘤瓦克霉素的生物合成揭示了涉及多重糖基化、羟基化、双O-乙酰化和氨基甲酰化等修饰步骤的空间时间顺序。

science china chemistry

IF0

2025-07-040

PRE

Enzyme-Catalyzed Molecular Skeletal Editing: α-Pyrone to Furanone

酶催化分子骨架编辑：α-吡喃酮到呋喃酮

IF13.1

2025-07-020

PRE

Transcriptomics-Driven Discovery of New Meroterpenoid Rhynchospenes Involved in the Virulence of the Barley Pathogen Rhynchosporium commune

ACS CHEMICAL BIOLOGY

IF3.8

2025-02-120

PRE

Enzymatic Insights into the Unusual Formation of Benzolactone and Benzopyran in the Biosynthesis of Spiromarmycin

酶学视角下螺马霉素生物合成中苯 lactone 和苯并吡喃的异常形成

IF13.1

2025-01-311

PRE

Metabolic Blockade-Based Genome Mining of Malbranchea circinata SDU050: Discovery of Diverse Secondary Metabolites

IF5.4

2025-01-200

OAAI

Antarmycins: Discovery, Biosynthesis, Anti-pathogenic Bacterial Activity, and Mechanism of Action from Deep-Sea-Derived Pseudonocardia antarctica

IF8.7

2024-12-180

OAAI

Self-Resistance Gene-Guided Discovery of the Molecular Basis for Biosynthesis of the Fatty Acid Synthase Inhibitor Cerulenin

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

IF16.9

2024-11-060

PRE

Efficient Mutasynthesis of Non-Natural Antitubercular Ilamycins with Low Cytotoxicity

ACS SYNTHETIC BIOLOGY

IF3.9

2024-03-055

PRE

Discovery and heterologous biosynthesis of glycosylated polyketide luteodienoside A reveals unprecedented glucinol-mediated product offloading by a fungal carnitine O-acyltransferase domain

CHEMICAL SCIENCE

IF7.4

2024-01-012

OAAI

Identification of a Potential Antimycobacterial Drug Sensitizer Targeting a Flavin-Independent Methylenetetrahydrofolate Reductase

IF4.3

2023-10-041

OAAI

Structural and functional characterization of a mycobacterial methylenetetrahydrofolate reductase utilizing NADH as the exclusive cofactor

BIOCHEMICAL JOURNAL

IF4.3

2023-07-192

OA

Diversity of Fungal Communities on Diseased and Healthy Cinnamomum burmannii Fruits and Antibacterial Activity of Secondary Metabolites

MICROBIOLOGY SPECTRUM

IF3.8

2023-06-153

OAAI

Refactoring and Heterologous Expression of Class III Lanthipeptide Biosynthetic Gene Clusters Lead to the Discovery of N,N-Dimethylated Lantibiotics from Firmicutes

ACS CHEMICAL BIOLOGY

IF3.8

2023-03-0914

OA

Investigations into the antibacterial effects and potential mechanism of gambogic acid and neogambogic acid

FRONTIERS IN MICROBIOLOGY

IF4.5

2022-12-127

OAAI

The Effect of Cardiac Rehabilitation on Lipid Levels in Patients with Coronary Heart Disease. A Systematic Review and Meta-Analysis

IF3.1

2022-11-2910

OAAI

Structural basis of transcription activation by Rob, a pleiotropic AraC/XylS family regulator

NUCLEIC ACIDS RESEARCH

IF13.1

2022-05-3117

OAAI